Ticker Symbol: ARFXF

ProMIS Neurosciences Inc.

Exchange: US OTC Country: CA Currency: USD Asset Type: Common Stock CIK:0001374339

Company Profile

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Sector: Health Technology

Industry: Biotechnology

Standard Industrial Classification Code (SIC code): 2836

Address: 1920 Yonge Street

Website: http://www.promisneurosciences.com

CEO: Elliot Goldstein

Tags:

Biotechnology
Health Technology

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $0.09 - $0.10

Beta: -

52wk. High: $0.21

52wk. Low: $0.07

Ytd. Change -10.45%

50 Day Moving Average: $0.08

200 Day Moving Average: $0.09

Shares Outstanding: 431731591

Valuation

Market Cap: 4.4B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A